Stocks of Aerovate Therapeutics Inc (NASDAQ:AVTE) traded higher last session on Wall Street, down -14.55% to $1.41.
AVTE stock price is now -93.21% away from the 50-day moving average and -92.42% away from the 200-day moving average. The market capitalization of the company currently stands at $40.64M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $35 to $2, Wells Fargo Downgraded its rating from Overweight to Equal Weight for Aerovate Therapeutics Inc (NASDAQ: AVTE). , while ‘Evercore ISI’ rates the stock as ‘In-line’
In other news, Eldridge George A, insider sold 15,000 shares of the company’s stock on Jun 14 ’24. The stock was sold for $375,450 at an average price of $25.03. Upon completion of the transaction, the insider now directly owns 5,022 shares in the company, valued at $7081.02. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 14 ’24, CHIEF TECHNICAL OFFICER Verwijs Marinus sold 10,600 shares of the business’s stock. A total of $265,000 was realized by selling the stock at an average price of $25.00. A total of 33.29% of the company’s stock is owned by insiders.
During the past 12 months, Aerovate Therapeutics Inc has had a low of $1.50 and a high of $32.42. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 6.65, and a quick ratio of 6.65. The fifty day moving average price for AVTE is $20.2604 and a two-hundred day moving average price translates $18.532425 for the stock.
The latest earnings results from Aerovate Therapeutics Inc (NASDAQ: AVTE) was released for 2024-03-31.
